WHO ICTRP trial
JPRN-jRCT2080223472
JPRN-jRCT2080223472 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080223472 |
|---|---|
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Japan;Asia except Japan;Europe;Oceania |
| Interventions | investigational material(s) Generic name etc : INN of investigational material : ruxolitinib Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : control material(s)… |
| Registration date | Feb 3, 2017 |
| Target size | 308 |
| Secondary IDs | NCT02913261;JapicCTI-173527 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: